See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 15, 2009

Depression Type 2 Diabetes (Metformin Users) Metastatic Colorectal Cancer - PEAK Study

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Depression

This study seeks people diagnosed with depression that have not fully responded to an antidepressant medication. The study will evaluate newly developed brain imaging methods that will allow participants to help control brain activation.

The research site is in Menlo Park, Calif.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/depression.aspx.

-----

Type 2 Diabetes (Metformin Users)

This study will evaluate the safety and tolerability of an investigational medication for type 2 diabetes. Participants will take daily capsules of the investigational drug along with their usual dose of Metformin.

The research site is in High Point, N.C.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.

-----

Metastatic Colorectal Cancer - PEAK Study

This study is for people with colorectal cancer that has metastasized (spread). The study will evaluate an investigational fully human monoclonal antibody combined with chemotherapy to see if it extends survival.

The research site is in Indianapolis, Ind.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/colorectal_cancer.aspx.

-----

Copyright 2009 ClinicalConnection.com. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.